214 related articles for article (PubMed ID: 29311344)
21. Recurrent events after percutaneous closure of patent foramen ovale.
Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
[TBL] [Abstract][Full Text] [Related]
22. The best DEFENSE for high-risk patent foramen ovale: An updated meta-analysis of six randomized trials.
Kokkinidis DG; Palaiodimos L; Mastoris I; Karamanis D; Faillace RT
Arch Cardiovasc Dis; 2019 Mar; 112(3):150-152. PubMed ID: 30594572
[No Abstract] [Full Text] [Related]
23. P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism?
Acampa M; Guideri F; Tassi R; Dello Buono D; Celli L; di Toro Mammarella L; Lazzerini PE; Marotta G; Lo Giudice G; D'Andrea P; Martini G
Int J Cardiol; 2015; 190():202-4. PubMed ID: 25920025
[No Abstract] [Full Text] [Related]
24. Device closure for patent foramen ovale in patients with cryptogenic stroke: a paradigm in evidence.
Ha FJ; Adams H; Palmer S
Med J Aust; 2019 Oct; 211(8):343-344.e1. PubMed ID: 31523821
[No Abstract] [Full Text] [Related]
25. Patent foramen ovale and ischemic stroke recurrence: the end of a never-ending story?
Tamayo A; Harrer JU
Neurology; 2009 Jul; 73(2):84-5. PubMed ID: 19439718
[No Abstract] [Full Text] [Related]
26. Prevention of stroke in patients with patent foramen ovale.
Mattle HP; Meier B; Nedeltchev K
Int J Stroke; 2010 Apr; 5(2):92-102. PubMed ID: 20446943
[TBL] [Abstract][Full Text] [Related]
27. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.
Bonvini RF; Sztajzel R; Dorsaz PA; Righini M; Bonvin C; Alibegovic J; Sigwart U; Camenzind E; Verin V; Sztajzel J
Int J Stroke; 2010 Feb; 5(1):4-9. PubMed ID: 20088986
[TBL] [Abstract][Full Text] [Related]
28. Risk of cerebrovascular events in patients with patent foramen ovale and intracardiac devices.
Poddar KL; Nagarajan V; Krishnaswamy A; Bajaj NS; Kumari M; Bdair H; Modi D; Agarwal S; Goel SS; Parashar A; Tuzcu EM; Kapadia SR
JACC Cardiovasc Interv; 2014 Nov; 7(11):1221-6. PubMed ID: 25326741
[TBL] [Abstract][Full Text] [Related]
29. Patent foramen ovale and obstructive sleep apnoea: from pathophysiology to diagnosis of a potentially dangerous association.
Pellaton C; Heinzer R; Michel P; Eeckhout E
Arch Cardiovasc Dis; 2011 Apr; 104(4):242-51. PubMed ID: 21624791
[TBL] [Abstract][Full Text] [Related]
30. Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials.
Pasceri V; Pelliccia F; Bressi E; Mantione L; Gaudio C; Speciale G; Mehran R; Dangas GD; Patti G
Int J Cardiol; 2018 Sep; 266():75-80. PubMed ID: 29887476
[TBL] [Abstract][Full Text] [Related]
31. [Secondary prevention of ischemic stroke--part 2].
Hamann GF; Liebetrau M
Fortschr Neurol Psychiatr; 2013 Jan; 81(1):44-53; quiz 54-5. PubMed ID: 23340971
[No Abstract] [Full Text] [Related]
32. Cryptogenic Stroke: Research and Practice.
Yaghi S; Bernstein RA; Passman R; Okin PM; Furie KL
Circ Res; 2017 Feb; 120(3):527-540. PubMed ID: 28154102
[TBL] [Abstract][Full Text] [Related]
33. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients.
Rizos T; Wagner A; Jenetzky E; Ringleb PA; Becker R; Hacke W; Veltkamp R
Cerebrovasc Dis; 2011; 32(3):276-82. PubMed ID: 21893980
[TBL] [Abstract][Full Text] [Related]
34. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
[TBL] [Abstract][Full Text] [Related]
35. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
[TBL] [Abstract][Full Text] [Related]
36. A brain-heart team approach to PFO.
Garratt KN; Horlick E; Kavinsky C; Rosenfield K
Catheter Cardiovasc Interv; 2017 Nov; 90(6):879-880. PubMed ID: 29148245
[No Abstract] [Full Text] [Related]
37. Risk of Ischemic Stroke in High Risk Atrial Fibrillation Patients during Periods of Warfarin Discontinuation for Surgical Procedures.
Qureshi AI; Jahangir N; Malik AA; Afzal MR; Orfi F; Suri MF
Cerebrovasc Dis; 2016; 42(5-6):346-351. PubMed ID: 27322535
[TBL] [Abstract][Full Text] [Related]
38. Stroke prevention by percutaneous closure of patent foramen ovale: a meta-analytic review.
Nagaraja V; Eslick GD
Int J Cardiol; 2014 Mar; 172(2):524-6. PubMed ID: 24485622
[No Abstract] [Full Text] [Related]
39. Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.
Zhang XL; Kang LN; Wang L; Xu B
BMC Cardiovasc Disord; 2018 Mar; 18(1):45. PubMed ID: 29499641
[TBL] [Abstract][Full Text] [Related]
40. Patent foramen ovale closure and subsequent atrial fibrillation.
Tobis J
Catheter Cardiovasc Interv; 2009 Nov; 74(6):896. PubMed ID: 19902510
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
